Investor Presentation Q1 2023 slide image

Investor Presentation Q1 2023

17 Investor presentation First three months of 2023 Appendix Novo Nordisk corporate strategy Diabetes care GLP-1 Insulin 18 31 40 46 Obesity care 51 Rare disease 70 Other serious chronic diseases 83 Regional information 101 Financials 133 Sustainability 143
View entire presentation